Procter & Gamble Health Ltd.(IN:PGHL)
₹5,823.70+17.60 (+0.30%)
IN:PGHL
Procter & Gamble Health Ltd. financials statements
₹5,823.70
At close:+17.60 (+0.30%)
Want to see IN:PGHL full AI Analyst Report?
Procter & Gamble Health Ltd. (PGHL) Financial Statements
4 Followers
Procter & Gamble Health Ltd. Financial Overview
Procter & Gamble Health Ltd.'s market cap is currently ₹96.24B. The company's EPS TTM is ₹214.99; its P/E ratio is 25.39; and it has a dividend yield of 3.64%. Procter & Gamble Health Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 14.08B | ₹ 12.18B | ₹ 11.51B | ₹ 12.30B | ₹ 11.14B |
| Gross Profit | ₹ 7.97B | ₹ 8.69B | ₹ 8.09B | ₹ 8.46B | ₹ 7.61B |
| Operating Income | ₹ 4.33B | ₹ 6.33B | ₹ 5.37B | ₹ 5.59B | ₹ 4.77B |
| EBITDA | ₹ 4.74B | ₹ 3.65B | ₹ 3.07B | ₹ 3.24B | ₹ 2.70B |
| Net Income | ₹ 3.27B | ₹ 2.51B | ₹ 2.01B | ₹ 2.29B | ₹ 1.93B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 1.85B | ₹ 1.89B | ₹ 2.44B | ₹ 4.53B | ₹ 3.19B |
| Total Assets | ₹ 8.41B | ₹ 7.94B | ₹ 7.94B | ₹ 11.01B | ₹ 8.94B |
| Total Debt | ₹ 92.90M | ₹ 76.20M | ₹ 95.60M | ₹ 120.00M | ₹ 28.30M |
| Net Debt | ₹ -1.76B | ₹ -1.81B | ₹ -2.35B | ₹ -4.23B | ₹ -3.17B |
| Total Liabilities | ₹ 3.17B | ₹ 2.57B | ₹ 2.56B | ₹ 3.50B | ₹ 2.77B |
| Stockholders' Equity | ₹ 5.25B | ₹ 5.37B | ₹ 5.38B | ₹ 7.51B | ₹ 6.16B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 3.22B | ₹ 1.67B | ₹ 2.07B | ₹ 1.94B | ₹ 1.32B |
| Operating Cash Flow | ₹ 3.38B | ₹ 1.76B | ₹ 2.28B | ₹ 2.36B | ₹ 1.70B |
| Investing Cash Flow | ₹ 12.60M | ₹ 24.40M | ₹ -68.70M | ₹ -215.00M | ₹ -255.40M |
| Financing Cash Flow | ₹ -3.44B | ₹ -2.35B | ₹ -4.18B | ₹ -984.70M | ₹ -2.89B |
Currency in INR
